CE
CERo Therapeutics Holdings, Inc.
CERO · OTC
$0.01 +0.00% (+$0.00)
1M -33.54%
Market Cap $473.7K
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 79.91%
ROA 2,354.69%
Asset turnover 0.00x
Debt
57 /100
Moderate Current ratio 0.05x
Int. coverage 26.03x
Debt/Equity N/A
Stability
1 /100
Unstable Beta 0.16x
EPS volatility 7,214.36%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CERO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Ehrlich
Employees
8
Headquarters
South San Francisco
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report